Pharmaceuticals

Ursodeoxycholic Acid Market Revenue Projected To Hit $3.95 Billion By 2030 With 6.5% CAGR

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Ursodeoxycholic Acid Market Expected To Scale Between 2026 And 2030?

The ursodeoxycholic acid market has experienced rapid expansion over recent years. It is projected to increase from $0.96 billion in 2025 to $1.06 billion in 2026, showing a compound annual growth rate (CAGR) of 11.0%. The historical growth of this market can be attributed to various factors such as restricted production methods for ursodeoxycholic acid, its dependence on animal-derived extraction, growing awareness of liver disease management, an increase in treatments offered by hospitals and specialty clinics, and limited research on non-alcoholic fatty liver disease.

The ursodeoxycholic acid market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $1.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This projected growth during the forecast timeframe is primarily driven by progress in chemical and enzymatic synthesis methods, an increasing incidence of liver and biliary conditions, the proliferation of specialized clinics and research organizations, a rise in regulatory clearances for synthetic udca, and the creation of innovative drug delivery formulations. Key developments expected within this period encompass the growing occurrence of gallstones and cholestatic liver ailments, enhanced uptake of synthetic and biosynthetic udca, broadening of both oral and intravenous delivery pathways, expanding application in research and clinical studies for liver conditions, and an emphasis on tailored therapies and precise dosage adjustment.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24734&type=smp

What Key Drivers Are Fueling The Growth Of The Ursodeoxycholic Acid Market?

The increasing incidence of liver ailments is projected to boost the expansion of the ursodeoxycholic acid market in the future. These conditions, which include infections, inflammation, fatty liver, cirrhosis, and liver cancer, hinder the liver’s normal functioning. The growing occurrence of liver diseases is linked to higher alcohol intake, as chronic heavy drinking can result in liver damage over time. Ursodeoxycholic acid aids in managing liver diseases by enhancing bile flow and decreasing harmful bile acids, proving beneficial for conditions like primary biliary cholangitis. It improves patient recovery by slowing the advancement of liver damage and assisting in the breakdown of cholesterol gallstones, thereby boosting treatment effectiveness. For instance, data from April 2024, released by the Office for Health Improvement and Disparities, a UK-based government department, indicated 6,664 early deaths from liver disease in males and 3,929 in females. This represented a rise of 22.8% for males and 33.1% for females compared to 2023. Consequently, the escalating prevalence of liver diseases is a key factor propelling the ursodeoxycholic acid market.

What Are The Main Segments Within The Ursodeoxycholic Acid Market Segment Structure?

The ursodeoxycholic acid market covered in this report is segmented –

1) By Type: Synthetic Ursodeoxycholic Acid, Extraction Ursodeoxycholic Acid

2) By Route Of Administration: Oral, Intravenous, Subcutaneous

3) By Application: Gallstones, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Non-Alcoholic Fatty Liver Disease, Other Liver And Biliary Diseases

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

5) By End User: Hospitals, Specialty Clinics, Research Institutions, Other End Users

Subsegments:

1) By Synthetic Ursodeoxycholic Acid: Chemically Synthesized Ursodeoxycholic Acid, Biosynthetic Ursodeoxycholic Acid, Enzymatically Synthesized Ursodeoxycholic Acid

2) By Extraction Ursodeoxycholic Acid: Animal-Derived Ursodeoxycholic Acid, Bile Extracted Ursodeoxycholic Acid, Natural Source Extracted Ursodeoxycholic Acid

Which Trends Are Impacting The Progress Of The Ursodeoxycholic Acid Market?

Leading companies in the ursodeoxycholic acid (UDCA) market are concentrating on developing innovative treatments, such as bile acid derivatives, to improve the therapy for liver diseases, particularly cholestatic liver disorders. Bile acid derivatives refer to altered forms of bile acids used in medical interventions to boost liver function and manage liver conditions. For instance, in November 2024, Nora Pharma Inc., a pharmaceutical company based in Canada, launched a generic version of Ursodiol (ursodeoxycholic acid) for addressing cholestatic liver diseases, including primary biliary cholangitis (PBC). This medication is primarily employed to enhance liver function and slow the progression of liver damage, especially when started early in the disease. It also helps in dissolving and preventing cholesterol gallstones by modifying bile composition and decreasing toxic bile acids.

Who Are The Companies Participating In The Ursodeoxycholic Acid Market?

Major companies operating in the ursodeoxycholic acid market are Mankind Pharma Pvt. Ltd, Abbott Healthcare Pvt. Ltd., Shandong Octagon Chemicals Limited, J.S.C. Grindeks, Arch Pharmalabs, Ind Swift Laboratories Ltd., Symbiotec Pharmalab, Suzhou Tianlu Bio-pharmaceutical Co. Ltd, Zeal MediPharma, Prodotti Chimici e Alimentari S.P.A., Mitsubishi Tanabe Pharma Corporation, ICE Pharma Inc, Xi’an Tian Guangyuan Biotech Co. Ltd, Aamorb Pharmaceuticals Inc., Axplora Inc, Octavius Pharma Pvt. Ltd, Sichuan Elixir Pharmaceutical Co. Ltd, Signova Pharma Pvt. Ltd., Sinoway Industrial Co. Ltd, Valence Labs Pvt. Ltd.

Get The Full Ursodeoxycholic Acid Market Report:

https://www.thebusinessresearchcompany.com/report/ursodeoxycholic-acid-global-market-report

Which Region Holds The Highest Market Share In The Ursodeoxycholic Acid Market?

North America was the largest region in the ursodeoxycholic acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ursodeoxycholic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Ursodeoxycholic Acid Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/ursodeoxycholic-acid-global-market-report

Browse Through More Reports Similar to the Global Ursodeoxycholic Acid Market 2026, By The Business Research Company

Glutamic Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/glutamic-acid-global-market-report

Hyaluronic Acid Based Dermal Fillers Market Report 2026

https://www.thebusinessresearchcompany.com/report/hyaluronic-acid-based-dermal-fillers-global-market-report

Citric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/citric-acid-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795